DWTX Dogwood Therapeutics, Inc.

NASDAQ

$1.36

Dogwood Therapeutics, Inc. (DWTX) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is a loss of $0.15 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -29.2% since its last earnings release on August 13, 2026.

Dogwood Therapeutics, Inc. Missed Consensus Estimates

Thursday, August 13, 2026 · 8:30 AM ET

3rd Quarter, Sep 2026

Monday · 8:30 AM ET

Earnings Whisper

-

vs ($0.15)

Volatility

Enter your expectations below to reveal the current volatility.

Trend Analysis

Expectation

Earnings

Price action

Signals

Score

Sentiment

Grade

Life Cycle

Call Analysis

Earnings-AVWAP $2.20

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Dogwood Therapeutics, Inc.

Dogwood Therapeutics is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathic disorders.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.